Bafilomycin A1 treatment reduced the accumulation of LC3B by 15 μmol/L dovitinib in MCF-7 breast cancer cells, whereas it caused the increased accumulation of LC3B in MDA-MB-468 cells (Figure 3(b)). Here, MAP1LC3B is linked to breast cancer.